Clinical Trial

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…

Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at…

Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…

Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials…

The company expands its Phase 1 trial after early signals show BGE-102’s potential to address inflammation beyond the…

Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient’s immune system condition. While…

Phase 2 trial of autologous MPC therapy reports significant functional gains and clean safety, with wider implications for…

The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) today announce a new collaboration…

Fungal eye infections affect millions globally, with an especially high incidence in South and Southeast Asia. Yet, unlike…

Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer…

New clinical trial evidence suggests that replacing an American-style diet with a Mediterranean eating pattern, while still consuming…

A tailored low-intensity noise stimulus alleviated tinnitus symptoms in a Phase II trial, demonstrating promise for a non-masking,…

Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial